Activist 13D/13G Filings - Qualigen Therapeutics Inc. (QLGN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2022-05-27
09:22 am
Purchase		13GQualigen Therapeutics Inc.
QLGN		ALPHA CAPITAL ANSTALT3,525,042
9.990%		2,284,954increase
(+184.26%)		View
2022-01-04
9:08 pm
Sale		13GQualigen Therapeutics Inc.
QLGN		SABBY MANAGEMENT LLC0
0.000%		-1,960,000decrease
(Position Closed)		View
2021-12-06
5:04 pm
Purchase		13GQualigen Therapeutics Inc.
QLGN		SABBY MANAGEMENT LLC1,960,000
11.000%		1,960,000increase
(New Position)		View
2020-06-01
5:00 pm
Purchase		13GQualigen Therapeutics Inc.
QLGN		SEKISUI DIAGNOSTICS LLC1,980,233
15.800%		1,980,233increase
(New Position)		View
2020-06-01
4:46 pm
Purchase		13GQualigen Therapeutics Inc.
QLGN		Greenblock Capital LLC811,431
6.500%		811,431increase
(New Position)		View
2020-05-28
4:05 pm
Purchase		13GQualigen Therapeutics Inc.
QLGN		ALPHA CAPITAL ANSTALT1,240,088
9.900%		1,240,088increase
(New Position)		View
2020-02-14
09:56 am
Sale		13GQualigen Therapeutics Inc.
QLGN		Alyeska Investment Group L.P.425,000
4.200%		-147,890decrease
(-25.81%)		View
2020-01-28
7:18 pm
Sale		13GQualigen Therapeutics Inc.
QLGN		Step Michael D128,757
0.700%		-820,077decrease
(-86.43%)		View
2020-01-28
4:15 pm
Sale		13GQualigen Therapeutics Inc.
QLGN		Stonehenge Partners LLC334,872
1.700%		-812,317decrease
(-70.81%)		View